Drug information for NAPRELAN
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET, EXTENDED RELEASE; ORAL
EQ 375MG BASE
Prescription
NAPROXEN SODIUM
Naproxen
STAT TRADE
20353
2011-11-17 Medication Guide
2011-11-10 Letter
2011-11-09 Label
2009-11-06 Label
2009-08-10 Letter
2007-06-04 Letter
2006-01-20 Label
2006-01-20 Letter
2003-08-08 Review
TABLET, EXTENDED RELEASE; ORAL
EQ 500MG BASE
Prescription
NAPROXEN SODIUM
Naproxen
STAT TRADE
"
TABLET, EXTENDED RELEASE; ORAL
EQ 750MG BASE
Prescription
(Reference Drug)
NAPROXEN SODIUM
Naproxen
STAT TRADE
"
Drug Adverse Effects information for NAPRELAN
Role code
Indications
Reaction
# Reports
C
MULTIPLE SCLEROSIS
BREAST CANCER METASTATIC
3
C
MULTIPLE SCLEROSIS
COLON CANCER
3
C
MULTIPLE SCLEROSIS
CONCUSSION
2
C
MULTIPLE SCLEROSIS
FALL
2
C
MULTIPLE SCLEROSIS
FATIGUE
2
C
MULTIPLE SCLEROSIS
FEELING HOT
2
C
MULTIPLE SCLEROSIS
INTERVERTEBRAL DISC DISORDER
2
C
MULTIPLE SCLEROSIS
RASH GENERALISED
3
C
MULTIPLE SCLEROSIS
THYROID DISORDER
1
C
MULTIPLE SCLEROSIS
UNEVALUABLE EVENT
2
C
NEURALGIA
DIZZINESS
1
C
NEURALGIA
FEELING ABNORMAL
2
C
NEURALGIA
MENTAL IMPAIRMENT
2
C
NEURALGIA
TREMOR
1
C
NEURALGIA
VISION BLURRED
1
C
PAIN
CONCUSSION
2
C
PAIN
FALL
2
C
PAIN
FATIGUE
2
C
PAIN
FEELING HOT
2
C
PAIN
INTERVERTEBRAL DISC DISORDER
2
C
PAIN
UNEVALUABLE EVENT
2
C
PRODUCT USED FOR UNKNOWN INDICATION
COUGH
1
C
PRODUCT USED FOR UNKNOWN INDICATION
LOCALISED INFECTION
1
C
PRODUCT USED FOR UNKNOWN INDICATION
OROPHARYNGEAL PAIN
1
C
PRODUCT USED FOR UNKNOWN INDICATION
VERTIGO
1
C
PROPHYLAXIS
BREAST CANCER METASTATIC
3
C
PROPHYLAXIS
COLON CANCER
3
C
PROPHYLAXIS
RASH GENERALISED
3
C
PROPHYLAXIS
THYROID DISORDER
1
C
RELAPSING-REMITTING MULTIPLE SCLEROSIS
BLOOD PRESSURE INCREASED
1
C
RELAPSING-REMITTING MULTIPLE SCLEROSIS
BRADYCARDIA
1
C
SWELLING
CONCUSSION
2
C
SWELLING
FALL
2
C
SWELLING
FATIGUE
2
C
SWELLING
FEELING HOT
2
C
SWELLING
INTERVERTEBRAL DISC DISORDER
2
C
SWELLING
UNEVALUABLE EVENT
2
Ads by Google